[Monitoring treatment with biologics in non-infectious uveitis].
Biologics are increasingly being used in the treatment of non-infectious sight-threatening uveitis. While the advantages of biologics, such as avoidance of glucocorticoid side-effects or rapid control of intraocular inflammation therapy refractive to corticosteroids, cannot be dismissed the treating ophthalmologist should be aware of the specific risks. Biologics increase the risk for severe and atypical infections, lymphomas and other malignancies. Treatment should only be initiated when profound knowledge about indications, management and monitoring of treatment with biologics is readily available. Weighing up the risks versus the benefits should be made on an individual basis and guide patient consultation.
Laura Bassi Centre for Ocular Inflammation & Infection Center for Pathophysiology, Immunology & Infectiology, Medical University of Vienna, Kinderspitalgasse 15, 1090 Wien, Österreich. Talin.barisani@meduniwien.ac.at
T
T
Barisani-Asenbauer
D001688:Biological Products / Q000009:adverse effects* / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000379:methods*; D015817:Eye Infections; D006801:Humans; D016896:Treatment Outcome; D014605:Uveitis / Q000175:diagnosis* / Q000188:drug therapy*
D001688:Biological Products
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD007848
19821440
Br J Ophthalmol. 2011 May;95(5):699-704
20971789
Int Ophthalmol. 2010 Oct;30(5):495-500
20686916
Dig Dis. 2010;28(3):536-42
20926883
Can J Ophthalmol. 2010 Aug;45(4):352-8
20648092
BMJ. 2009 Jul 03;339:b2480
19578087
Curr Opin Ophthalmol. 2008 Nov;19(6):535-40
18854699
Curr Gastroenterol Rep. 2010 Dec;12(6):502-6
20890739
Surv Ophthalmol. 2005 Jan-Feb;50(1):27-47
15621076
Int Ophthalmol. 2010 Oct;30(5):453-64
19430730
Pharmacotherapy. 2010 Apr;30(4):339-53
20334454
Br J Ophthalmol. 2011 Apr;95(4):549-52
20584716
Am J Ophthalmol. 2005 Sep;140(3):509-16
16196117
Int J Cancer. 2000 Nov 1;88(3):497-502
11054684
Expert Opin Pharmacother. 2010 May;11(7):1135-46
20367272
Am J Ophthalmol. 2008 Dec;146(6):802-12.e1
18579112
Arch Ophthalmol. 2010 May;128(5):632-5
20457989
Ophthalmologe. 2005 Apr;102(4):325-8
15744489
BMJ. 2010 Oct 13;341:c4976
20943722
Clin Dermatol. 2010 Jan-Feb;28(1):81-7
20082956
Int Ophthalmol. 2010 Oct;30(5):539-52
18795232
Br J Ophthalmol. 2007 Feb;91(2):154-6
16973657
Am J Ophthalmol. 2008 Dec;146(6):813-8.e1
18687418
Autoimmun Rev. 2010 Oct;9(12):820-4
20667515
Ann Rheum Dis. 2009 May;68(5):648-53
18467516
Ophthalmology. 1994 Apr;101(4):728-35
8152769
Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):1-11
21182150
J Rheumatol Suppl. 2009 Jun;82:25-32
19509327